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Abstract
Background: Two hormetic modifications of a monotonically decreasing log-logistic dose-response function are most often
used to model stimulatory effects of low dosages of a toxicant in plant biology. As just one of these empirical models is yet
properly parameterized to allow inference about quantities of interest, this study contributes the parameterized functions
for the second hormetic model and compares the estimates of effective dosages between both models based on 23
hormetic data sets. Based on this, the impact on effective dosage estimations was evaluated, especially in case of a
substantially inferior fit by one of the two models.
Methodology/Principal Findings: The data sets evaluated described the hormetic responses of four different test plant
species exposed to 15 different chemical stressors in two different experimental dose-response test designs. Out of the 23
data sets, one could not be described by any of the two models, 14 could be better described by one of the two models,
and eight could be equally described by both models. In cases of misspecification by any of the two models, the differences
between effective dosages estimates (0–1768%) greatly exceeded the differences observed when both models provided a
satisfactory fit (0–26%). This suggests that the conclusions drawn depending on the model used may diverge considerably
when using an improper hormetic model especially regarding effective dosages quantifying hormesis.
Conclusions/Significance: The study showed that hormetic dose responses can take on many shapes and that this diversity
can not be captured by a single model without risking considerable misinterpretation. However, the two empirical models
considered in this paper together provide a powerful means to model, prove, and now also to quantify a wide range of
hormetic responses by reparameterization. Despite this, they should not be applied uncritically, but after statistical and
graphical assessment of their adequacy.
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Introduction
Reports of the phenomenon of stimulatory effects of low dosages
of a toxicant, or in fine hormesis, are accumulating in many
toxicological sciences and hormetic dose-response data sets appear
the rule rather than the exception [1,2]. Consequently, there has
been an increased interest in statistical models that incorporate
these effects [2,3]. Hormesis has been found within all groups of
organisms, for a wide range of endpoints, and it is induced by
physical or chemical stress factors including many herbicides and
other phytotoxins [4,5,6]. Although evidence has accumulated
that hormesis is a true and reproducible dose-response occurrence,
its authenticity has long been questioned and viewed as
experimental outlier, especially if only one dose exhibited a
response increase. Hence, one major concern of early research in
this field was to recognize those cases where hormesis exists and to
adequately establish the significance of the phenomenon [2,3].
Since the recognition of the entire dose-response curve provides
the strongest and most reliable basis for testing of hormesis, there
was a need for developing robust statistical models describing
hormetic effects [2]. Although meanwhile a broad class of
mathematical-statistical models exist that allow the incorporation
of hormesis and testing its significance, two empirical models
gained most credit for modeling hormetic data in dose-response
studies with natural or synthetic phytotoxins in plant biology. Both
are derivatives of the general monotonic log-logistic function most-
used in herbicide dose-response studies [7,8] and reduce to this in
the absence of hormesis [2,3]. The Brain and Cousens model [9] is
one of the earliest and well-known dose-response models allowing
for hormesis and the assessment of its significance (Equation (1)).
The model can be written as
Ey jx ½  ~cz
d{czfx
1zexp½bln(x=e) 
, ð1Þ
where c denotes the response at infinite doses, d denotes the mean
response of the untreated control, and f denotes the rate of
stimulation at doses close to zero (f.0 as a necessary condition for
the presence of hormesis), while parameters b and e have no
straightforward biological meaning [9]. Although the model has
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33432been successfully used in several plant studies (e.g., [3,10,11,
12,13]), it has some drawbacks making it not especially robust and
flexible when applied to real data [2]. Particularly the fact that the
model is confined to values of b larger than one can be problematic
if data giving curves with inherently low slopes are to be fit [2].
Based on the fact that Cedergreen et al. [2] could not find
significant hormesis modelling 51 dose-response data sets of
herbicide toxicity with the Brain and Cousens model [9], they
modified the equation by replacing fx in Equation (1) by fe{1=xa
(Equation (2)):
Eyx j ½  ~cz
d{czf exp {1=xa ðÞ
1zexp bln x=e ðÞ ½ 
, ð2Þ
where f denotes the theoretical upper bound of the hormetic effect
(f.0 as a necessary condition for the presence of hormesis), while
parameters a, b, and e have no straightforward biological meaning.
This new model was found to be much more robust and apt to
adequately fit 69% of the 51 dose-response data sets evaluated in
Cedergreen et al. [2]. Since its development, the model has been
successfully used in several studies on plant hormesis and was
shown to feature a higher flexibility to capture variation in
hormetic data (e.g., [6,14,15,16,17]). The only apparent drawback
seems to be the fact that the parameter a has to be fixed, because
there are rarely enough data available to determine the rate of
increase statistically [2]. Since their introduction both models have
been frequently used in plant biology and have considerably
helped to award the phenomenon of hormesis more respectability
in this research area by a sound statistical validation. However, as
the findings of significant hormesis were growing, the demands of
modelling this low-dose phenomenon changed from a mere proof
of its evidence to a precise statistical quantification of important
hormetic dosages with their standard errors and confidence
intervals [2,3,10]. Among the quantitative features describing the
expression of a hormetic response are the dose where the hormetic
effect is maximal (M), the response at dose M (ymax), the dose
where the hormetic effect disappears or the limited dose for
stimulation (LDS), and the dose causing 50% reduction in mean
response of the untreated control (ED50). Furthermore, the size of
the hormetic effect is often described by the dose range of the
hormetic zone representing the distance between M and LDS doses
and the distance between LDS and ED50 doses [2,10,18]. These
values are, however, not directly accessible applying either the
Brain and Cousens [9] or the Cedergreen et al. model [2] in its
initial forms (Equations (1) and (2)). In order to allow the direct
estimation of these dosages, Schabenberger et al. [10] reparame-
terized the Brain and Cousens model [9] to obtain estimates of M,
LDS, and arbitrary EDK doses with their standard errors and
confidence intervals. Cedergreen et al. [2] applied the delta
method and the statistical software R with the add-on package drc
to do so fitting their model to hormetic data. This, however, has
hitherto allowed merely estimating EDK doses with statistical
properties and to extract M doses but without standard errors or
confidence intervals. LDS dose estimations are lacking which is
why ED1 doses are usually estimated to characterize the transition
from stimulation to inhibition (e.g., [2,14,15]). Therefore,
applications of the Cedergreen et al. model [2] are currently
limited to cases where M estimations are sufficient without
statistical properties and where LDS estimations in form of ED1
doses are adequate. This is certainly applicable for most hormesis
evaluations, however, not so for example for the prediction of
hormesis in mixtures by joint action analysis [11]. To assess the
necessary quantities in such cases there is currently no other choice
of a properly parameterized function than the less flexible Brain
and Cousens model [9] even if the Cedergreen et al. model [2]
may fit the data better. The bias potentially incurred by relying on
a single model that is known to have serious drawbacks is critical,
since conclusions on treatment effects are conditional on the
suitability of the model used [3,10]. However, in order to judge a
potential impact of hormetic model selection on effective dose
estimates and the conclusions drawn from such evaluations, it is
necessary that both functions addressed herein are parameterized
properly to allow inference about stimulatory quantities.
The aim of the present work was therefore to provide a general
method for reparameterization of the Cedergreen et al. model [2]
to allow for the estimation of the effective dosages M and LDS and
arbitrary EDK doses with their standard errors and confidence
intervals. Based on this, the quantification of the hormetic effect by
the Cedergreen et al. [2] and the Brain and Cousens model [9]
was compared with regard to the aptness of describing various
empirical hormetic data sets and the impact on effective dose
estimations, especially in case of a substantially inferior fit by one
of the two models. For this purpose 23 data sets were evaluated
describing the hormetic responses of four different test plant
species exposed to 15 different chemical stressors in two different
experimental dose-response test designs.
Methods
Reparameterization
The estimation of effective dosages with the Brain and Cousens
model [9] by reparameterization through defining relationships is
described in detail in Schabenberger et al. [10]. Table 1 gives an
overview of the respective model expressions. Parameterizations of
the Cedergreen et al. model [2] were done by modifying the
nonlinear model to contain an EDK or an M dosage by defining a
conditional equation that was then plugged in for d in case of EDK
and for f in case of M values. LDS values represent the special case
of K=0. Upon replacing x by the respective target dosage in the
remodelled parameter equation, the latter replaced the respective
parameter in Equation (2). The target dosage can thus be directly
estimated with standard error and confidence interval.
Conditional Equation for EDK. To make the Cedergreen
et al. model [2] depend on an arbitrary effective dose for K%
inhibition [(100-K)% response] the defining relationship is
Table 1. Parameterizations of the Brain and Cousens model
[9] after Schabenberger et al. [10] to estimate particular
dosage effects.
Parameterization for estimating EDK
Ey jx ½  ~cz
d{czfx
1z
K
100{K
z
100
100{K
|
fEDK
d{c

exp bln x=EDK ðÞ ½ 
Parameterization for estimating LDS (EDK=0)
Ey jx ½  ~cz
d{czfx
1z
fLDS
d{c

exp bln x=LDS ðÞ ½ 
Parameterization for estimating M
Ey jx ½  ~cz
d{czfx
1z
fM
(d{c)b{fM(1{b)

exp bln x=M ðÞ ½ 
doi:10.1371/journal.pone.0033432.t001
Modelling Hormesis Quantities
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33432Eyx j ½  ~cz
100{K
100
|d{c ðÞ ~cz
d{czf exp {1=EDK
a ðÞ
1zexp bln EDK=e ðÞ ½ 
: ð3Þ
Solving Equation (3) for d (Table 2) and substituting into Equation
(2) yields a hormetic dose-response model with five parameters (c,
b, e, f and EDK) allowing for the estimation of any effective dosage.
In terms of ED50, for example, the model expression corresponds
to
Ey jx ½  ~cz
d{czf exp {1=xa ðÞ
1zexp bln x=e ðÞ ½ 
ð4Þ
with
d~ 0:5{
1
1zexp bln(ED50=e) ½ 
 {1
|
{czf exp({1=ED50
a)
1zexp bln(ED50=e) ½ 
z0:5c

.
Conditional Equation for M. Here, the premise that the
first derivative of f with respect to x must equal zero defines the
following relationship
dE y x j ½ 
dx
~0~
f exp({1=Ma)(aM{a{1)
1zexp½bln(M=e) 
{
d{czf exp({1=Ma)
(1zexp½bln(M=e) )
2
|exp½bln(M=e) |
b
M
: ð5Þ
Solving Equation (5) for f (Table 2) and substituting into Equation
(2) yields a hormetic dose-response model with five parameters (d,
c, b, e, and M). As stated by Schabenberger et al. [10], the
reparameterized equations appear complicated at first view, but
can be coded easily into a nonlinear regression package (Tables S1
and S2).
Biological Data
The models were tested on 23 dose-response data sets that were
generated using two different bioassay designs. The first set of data
resulted from germination bioassays that evaluated the effect of
various phytotoxins, their binary mixtures or phytotoxic plant
extracts on the root length growth of different test plant species
(Amaranthus hybridus L., Lactuca sativa L., or Medicago sativa L.). The
second data set consisted of produced root length of Sinapis alba L.
exposed to root exudates of cereal crops in a hydroponic co-
culture.
Germination Bioassays. The hormetic effect of two natural
isothiocyanates (allyl- and 2-phenylethyl-isothiocyanate; Lancaster
Synthesis) was evaluated using A. hybridus as test species. A. hybridus
seeds were exposed for 7 d in Petri dishes in a growth cabinet to
aqueous solutions of the isothiocyanates in concentrations ranging
from 0–1 mmol/ml under the conditions described in Petersen
et al. [19]. L. sativa cv. Maiko ¨nig (lettuce) was used to test the effect
of: (1) natural phytotoxins [parthenin, tetraneurin-A (isolated as
described in Belz et al. [20]); 2-amino-3H-phenoxazin-3-one
(APO; synthesized after Gagliardo and Chilton [21]); trans-ferulic
acid (Aldrich)], (2) synthetic phytotoxins [2-(p-chlorophenoxy)-2-
methylpropionic acid (PCIB; Aldrich), glyphosate (Glyfos, Glyfos
Supreme (Sta ¨hler GmbH); Roundup Speed (Scotts Celaflor)], (3)
phytotoxic plant leaf extracts of Parthenium hysterophorus L.
(produced as described in Belz et al. [20]), or (4) mixtures of
these. Either seeds of L. sativa or, in case of glyphosate treatments,
2 d-old seedlings pregerminated in methanol (4%) were exposed
for 5 d in 6-well cell culture plates in a growth cabinet to aqueous
solutions of the phytotoxins (0–148 mmol/ml) or the leaf extract
(0–27 mg dry mass/ml). Lettuce assays were performed under the
conditions described in Belz et al. [11]. M. sativa was used to
evaluate the effect of the natural phytotoxin benzoxazolin-2(3H)-
one (BOA; Fluka). Seeds of M. sativa were exposed for 6 d in Petri
dishes in a growth cabinet to aqueous BOA solutions in
concentrations ranging from 0–4 mmol/ml under the conditions
described in Belz et al. [22]. The final root length ($1 mm) was
measured as response variable for all test species.
Hydroponic co-culture. The hormetic effect of plant-
produced phytotoxins in root exudates of Triticum aestivum L. cv.
Contra or Hordeum vulgare L. cv. Finesse on root length growth of S.
alba cv. Albatros was evaluated by a co-culture of four
pregerminated S. alba plants with increasing densities of
pregerminated crop plants (0–30 plants/290 ml) in hydroponics.
Assays were performed under greenhouse conditions for 5 d under
the conditions described in Belz and Hurle [23]. The increase in
root length of S. alba was measured as response variable.
Statistical methods
Root length (y) as a function of dose (x) was fitted to Equations
(1) and (2) using IBM SPSSH Statistics (estimation method
Levenberg-Marquardt; convergence criterion=1   e{8). Re-
sponse variance was stabilized at each dose by using the inverse
standard deviation of replicates as weight. All data were fitted to
models using a lower limit of zero for c. All parameters were freely
estimated with the exception of a in Equation (2) that was fixed
between 0.07 and 1.75 according to the smallest residual sum of
squares when hormetic responses could not be described without
restrictions on a [2]. The range of preset a values was broadened as
compared to Cedergreen et al. [2] in order to cope with the wide
range of hormetic responses in the present data sets. The values of
M, LDS, and ED50 were estimated by reparameterizations
according to Schabenberger et al. [3,10] for the Brain and
Table 2. Parameterizations of the Cedergreen et al. model [2] to estimate particular dosage effects.
Parameterization for estimating EDK: parameter to be replaced in Equation (2)
d~
100{K
100
{
1
1zexp bln(EDK=e) ½ 
 {1
|
{czf exp({1=EDK
a)
1zexp bln(EDK=e) ½ 
z
c(100{K)
100

Parameterization for estimating LDS (EDK=0): parameter to be replaced in Equation (2)
d~ 1{
1
1zexp bln(LDS=e) ½ 
 {1
|
{czf exp({1=LDSa)
1zexp bln(LDS=e) ½ 
zc

Parameterization for estimating M: parameter to be replaced in Equation (2)
f~ exp {1=Ma ðÞ | aM{a{1 
| 1zexp bln M=e ðÞ ½  fg {exp {1=Ma ðÞ |exp bln M=e ðÞ ½  |
b
M
 {1
| d{c ðÞ |exp bln M=e ðÞ ½  |
b
M

doi:10.1371/journal.pone.0033432.t002
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for the Cedergreen et al. model [2]. Data were first fitted to the
original models (Equations (1) and (2)) using starting values for
parameters that were graphically deduced from raw data graphs.
Parameter d was preset according to the mean value of the
untreated control, f was preset at either 0, 1, 10, or 100 depending
on the size of the hormetic response, a was also set according to the
size of the hormetic response at 0.1, 0.5, or 1, b was preset between
1–3 depending on the steepness in the inhibitory dose range, and
the starting value for e was preset slightly lower than the
graphically anticipated ED50. If the iteration failed, the starting
values were adapted so long as all parameters could be properly
estimated. These final starting values were subsequently used for
reparameterizations of effective doses whose starting values were
preset according to the graphically anticipated values. The
corresponding response ymax (absolute and relative to d)a tM
was calculated as estimation at x=M with standard error and
confidence interval using SASH.
Significance of hormesis. The significance of hormesis was
assessed by the estimation of f for both models [2,10]. According to
Schabenberger et al. [10] a hormetic effect is significant at the 0.05
probability level if the 95% confidence interval (CI95) for the
estimate of f does not cover the value zero. With both models
either the original models (Equations (1) and (2)) can be used to test
for hormesis or their EDK parameterizations (Tables 1 and 2).
Model comparisons. The quality of the description of
responses by the regression models was initially assessed by an F
test for lack-of-fit (a=0.05) and by graphical agreement between
observed and fitted values. Model comparisons for best fit were
furthermore based on residual sum of squares and residual degrees
of freedom (SSres/dfres) and the Pseudo-R
2 measure (1-SSres/
SScorrected) that can be used as a quality parameter for the models
used here although with caution [10]. The importance of
differences between estimated parameters and effective doses of
the two models was judged by the degree of overlap of the CI95.A s
this decision rule does not provide the intended 5% type-I error
rate [10], it serves merely as an indication for the likelihood of
significant differences. Finally, the relative bias between model
estimates was calculated following Schabenberger and Birch [3] as
100*(estimate2-estimate1)/estimate1 where estimate1 represents
the values derived from the model providing the better fit.
Results
Case 1 – both models not suitable
Out of the 23 hormetic data sets evaluated in this study there
was one data set describing the phytotoxic effect of the
isothiocyanate 2-phenylethyl that could neither be properly fitted
by the Cedergreen et al. model [2] nor the Brain and Cousens
model [9] although an analysis of variance with Dunnett’s t test
(.control; a=0.05) proved two doses as significantly enhanced
(Figure 1A). Despite Pseudo-R
2 values of 0.934 for both models,
the graphical agreement between observed and fitted values was
poor in each case and the CI95 of both f values covered zero
indicating no significant hormesis (Table S3). The reasons for the
inaptness of both models to capture the apparent stimulation may
involve the fact of only two hormetic doses and the steepness of
the dose-response relationship in the inhibitory dose zone
(average b=5.8560.04). In search of alternative models, the
data could be statistically adequately described by the An-
Johnson-Lovett Model II [24], a hormesis model based on the
ecological-limiting-factor model of Mitcherlich (Figure 1B).
Furthermore, modelling with this function proved a significant
hormetic effect as the CI95 of the two model parameters
describing stimulatory responses in this function did not include
zero (Table S3). However, although the goodness-of-fit Pseudo-R
2
value of 0.938 for the An-Johnson-Lovett Model II [24] indicated
a satisfactory fit, the graphical comparison between observed
values and the fitted curve suggests a risk of overestimating the
actual hormetic effect. A more adequate spacing of experimental
units within the hormetic dose zone would, however, be necessary
to assess this risk.
Case 2 – Brain and Cousens model more suitable
Out of the 23 hormetic data sets there were six obtained with
the lettuce assay where the Brain and Cousens model [9] was
judged more suitable. At five of these data sets, the Cedergreen
et al. model [2] failed to detect significant hormesis in contrast to
the Brain and Cousens model [9]. Modelling these five data sets
with the Cedergreen et al. model [2] revealed in fact a better
goodness-of-fit as judged by lower SSres/dfres values and the
Pseudo-R
2 values (0.803–0.943 compared to 0.720–0.920 for the
Brain and Cousens model [9]), however, all f values were not
Figure 1. Both logistic hormetic models unsuitable. Dose-response relationship for the effect of 2-phenylethyl-isothiocyanate on root growth
of Amaranthus hybridus and its description by the hormetic dose-response models after Brain and Cousens [9] (grey curve) or Cedergreen et al. [2]
(black curve) (A). (B) Response modelling by the An-Johnson-Lovett Model II [24] (black curve). Only the An-Johnson-Lovett Model II [24] showed a
significant hormetic effect. Error bars represent standard deviation.
doi:10.1371/journal.pone.0033432.g001
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on the parameter a (Figures 2A–E; Table S4). Based on the
observed significance of f values and the reasonable graphical
agreement, we rated the Brain and Cousens model [9] more
suitable for these five data sets, however, a more data- and
goodness-of-fit-driven judgment may still favour the Cedergreen et
al. model [2]. The five data sets comprised all three data sets of
parthenin effects, one of five data sets of PCIB effects, and the
tetraneurin-A treatment. Modelling the effect of a phytotoxic plant
leaf extract revealed a significant hormetic effect with both models;
however, this time the goodness-of-fit as well as the graphical
agreement was better with the Brain and Cousens model [9]
(Figure 2F; Table S4). Thus, out of the 23 data sets evaluated,
there was only one where the Cedergreen et al. model [2] clearly
provided an inferior fit. Notably, all of these six data sets included
at least one data point below the control causing a more or less
pronounced drop of the Cedergreen et al. curve [2] for five data
sets (Figure 2A–E). With such a drop of the curve, the
reparameterized functions for hormetic dosages have more than
one solution. Thus, depending on the starting values for effective
hormetic doses the initial drop can be quantified by the dose where
the drop is maximal (Mmin), the response at dose Mmin (ymin), and
the dose where the drop disappears and the hormetic effect begins
(LDSmin) (Figure 2E). In case of tetraneurin-A for example, a
maximum low dose inhibition of 14% was observed at a dose of
Mmin=0.03060.002 mmol/ml disappearing at LDSmin=0.0606
0.001 mmol/ml (Figure 2E). Furthermore, the distance between
Mmin and M comprised a 6.4-fold dose increase and the distance
between LDSmin and LDS representing the hormetic dose zone
was 10-fold. Hence, the Cedergreen et al. model [2] allows
modelling and quantifying this rather unusual feature in hormetic
data sets, however, the significance of this low dose toxicity can
not be as easily determined as the significance of the stimulatory
response by f estimation. This would be important, however, in
order to judge whether the phenomenon is biologically relevant
or just due to experimental variation. Even so, the Cedergreen et
al. model [2] proved to be more flexible than the Brain and
Cousens function [9] to model hormetic data sets where there is a
drop of responses before the initiation of the stimulatory
response, just that it failed to indicate the significance of hormesis
in such cases.
Comparing the estimates of effective dosages of the two models
showed that in all six data sets confidence intervals of ED50
estimates included the estimate of the other model indicating that
differences are not likely to be significant at this response level. In
contrast, CI95 of hormetic quantities did not overlap between the
two models for three of the six data sets, whereby all three curves
showed notable variations in M estimates, two in ymax, and one in
LDS values. The magnitude of deviations between both models
ranged between 4–25% for M and LDS estimates and 2–8% for
ymax estimates (Table S5). Thus, while estimates of effective doses
in the inhibitory dose range proved widely unaffected if the
Cedergreen et al. model [2] failed to significantly model the
hormetic effect or provided an inferior fit, quantities characteriz-
ing the hormetic effect were more likely impaired.
Case 3 – Cedergreen et al. model more suitable
Out of the 23 hormetic data sets there were eight where the
Brain and Cousens model [9] was less suitable to describe the
hormetic response (Figure 3). These eight data sets comprised
three of five data sets of PCIB effects in the lettuce assay, all
glyphosate treatments, one mixture data set, and one data set
reflecting the effect of root exudates of a barley cultivar in the
hydroponic bioassay. Although for all these data sets the Brain and
Figure 2. Brain and Cousens model more suitable. Dose-response relationships for effects of different phytotoxins and an aqueous leaf extract
of Parthenium hysterophorus at the flowering stage on root growth of Lactuca sativa and their description by the hormetic dose-response models
after Brain and Cousens [9] (grey curve) or Cedergreen et al. [2] (black curve). The Cedergreen et al. model [2] did not detect significant hormetic
responses (f,0) (A–E) or provided an inferior fit (F). Error bars represent standard deviation. DM=dry leaf mass.
doi:10.1371/journal.pone.0033432.g002
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PLoS ONE | www.plosone.org 5 March 2012 | Volume 7 | Issue 3 | e33432Figure 3. Cedergreen et al. model more suitable. Dose-response relationships for effects of different phytotoxins on root growth of Lactuca
sativa (A–G) and for effects of root exudates of Hordeum vulgare on root growth of Sinapis alba (H) and their description by the hormetic dose-
response models after Brain and Cousens [9] (grey curve) or Cedergreen et al. [2] (black curve). The Brain and Cousens model [9] detected significant
hormetic responses, but provided inferior fits. Error bars represent standard deviation.
doi:10.1371/journal.pone.0033432.g003
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R
2 values ranging between 0.874 and 0.969 indicated a satisfactory
fit, the graphical agreement between observed and fitted values
was partly poor and clearly inferior to the Cedergreen et al.
modelling [2]. This was further manifested by consistently lower
SSres/dfres and each time higher Pseudo-R
2 values (0.894–0.967)
for the Cedergreen et al. modelling [2] (Table S6).
Regarding the shaping of the dose response data that could be
better described by the Cedergreen et al. model [2] it is noted that
most of these data sets were characterized by an early increase in
responses at low doses and a broad hormetic dose range. The
average distance between M and LDS doses as estimated by the
Cedergreen et al. function [2] was a 50.3-fold increase in doses as
compared to an average of 2.7-fold observed in cases where the
Brain and Cousens model [9] provided a better fit (Figure 2).
Comparing the CI95 of estimates of effective dosages of the two
models showed notable differences at all eight data sets with a
considerable bias at all response levels. Non-overlapping CI95
between model estimations appeared at four data sets at the ED50
response level where the Brain and Cousens estimates [9] differed
between 5–61% from the values estimated with the Cedergreen
et al. model [2]. CI95 of LDS estimates did not overlap for five data
sets and variations ranged between 7–37%. CI95 of M and ymax
estimates did not overlap for six data sets with the relative bias
being most pronounced for M values (3–1768%) and least
pronounced for ymax (0–23%) (Table S5). Thus, in cases where
the Brain and Cousens model [9] provided a statistically
satisfactory but inferior fit as compared to the Cedergreen et al.
model [2], effective dosage estimations displayed a severe bias at
all response levels, especially at the M dose level.
Case 4 – both models equally suitable
Out of the 23 hormetic data sets there were eight where both
models were equally suitable to describe the hormetic response as
judged by marginal differences in SSres/dfres and Pseudo-R
2 values
and a good graphical agreement between both model fittings.
Pseudo-R
2 values ranged between 0.879 and 0.977. Furthermore,
both models yielded a significant hormetic effect for all eight data
sets (Figure 4; Table S7). Among these eight data sets were the
single effects of allyl-isothiocyanate, APO, and BOA on lettuce,
one out of five data sets of PCIB effects, and one data set reflecting
the effect of root exudates of a wheat cultivar in the hydroponic
bioassay. Furthermore, three data sets describing binary mixture-
toxicity effects of phytotoxins that, if applied alone, induce
hormesis in the lettuce assay (PCIB, parthenin, and tetraneurin-
A) albeit the single effects of the mixture partners proved to be
better described by the other model in each case (Figure 4D–F).
Thus, joint actions of hormetic compounds showing oppositional
model preferences seem to alleviate misspecifications between the
two models.
Comparing the estimates of effective doses and ymax between
both models revealed overlapping CI95 for all quantities.
Notwithstanding, estimated values deviated with the divergence
increasing from less than 4% to up to 26% in the order
ED50,ymax,LDS,M (Table S5). Thus, although unlikely statis-
tically significant, the difference between model estimations was
again most pronounced in the hormetic dose range and here
especially concerning M doses whereby M estimates of the Brain
and Cousens model [9] always overestimated those obtained by
Cedergreen et al. fittings [2]. As a consequence, the estimated
hormetic dose zone as expressed as the distance between M and
LDS was consistently lower for the Brain and Cousens modelling
[9]. Hence, there are data sets where both models are obviously of
the same value regarding a proper description of hormetic
responses, but still there appears to be considerable inherent
deviation in hormetic quantities that may impair the conclusions
drawn depending on the model used.
Discussion
Results confirm that hormetic dose responses can take on many
shapes and that the shaping of the data determines which model
fits better [3]. The apparent diversity of hormesis may reflect
responses of, e.g., different hormetins, test organisms or species,
endpoints, or time periods. This increases requirements with
regard to modelling as compared to a less challenging monotonic
response. In order to cope with this diversity of hormetic
responses, clearly several hormetic candidate models should be
evaluated since there is no single best model that is flexible enough
to capture the entire variety of shapes and potentially unusual
patterns present in the data. However, the need for properly
parameterized models allowing inference about the significance of
hormesis and quantities of interest [2,10] narrows the range of
currently available functions down to the two models addressed
herein. Even so, this study and the study of Cedergreen et al. [2]
showed that the two models are able to cover a wide range of
hormetic dose responses in plant biology, with the Cedergreen
et al. model [2] proving more flexible and able to fit a broader
variety of shapes due to the introduction of a second hormetic
regression parameter a. Nevertheless, the current example of 2-
phenylethyl isothiocyanate substantiates that their flexibility with
regard to modelling is limited. If the observed inaptness results
from the extreme steepness of the curve in the inhibitory dose
range and/or a lack of data points within the hormetic dose zone
needs to be verified. Cedergreen et al. [2] recommended at least
4–5 hormetic doses to adequately describe and quantify a
hormetic response, which is clearly more than the two doses
exceeding the control in the current case of 2-phenylethyl
isothiocyanate. An adequate spacing of dosages is clearly a
prerequisite to reliably model the putative true shape of a hormetic
response, nevertheless, modelling hormetic responses with just 1–2
doses exhibiting a response increase is often observed in hormesis
research [2,10,13,17].
In cases where the two empirical models addressed herein are
inadequate, a range of alternative models are available to describe
and prove hormetic responses [3,24,25,26]. In the present case of
2-phenylethyl isothiocyanate, a proper statistical alternative to fit
the data was the An-Johnson-Lovett Model II [24]. However, as
this empirical model lacks a parameter describing the lower
response limit like the c value in the Brain and Cousens [9] and the
Cedergreen et al. [2] models, introducing an artificial maximum
response at a high dose was necessary to avoid a drop of the curve
to negative responses at higher doses. Thus, this model requires an
adequate spacing of responses in the hormetic and the inhibitory
dose ranges. Furthermore, as other alternatives, the model is not
parameterized to deduce effective quantities. Hence, in cases
where hormetic modelling is forced to switch to alternatives to a
Brain and Cousens [9] or a Cedergreen et al. [2] modelling,
quantification is intricate and requires advanced statistical skills.
The Cedergreen et al. model [2] constitutes an improved,
flexible expansion of the Brain and Cousens model [9] raising the
question if the latter is still a competitive model. Cedergreen et al.
[2] studied 51 dose-response data sets composed of large, relatively
small, and non-hormetic responses. The Cedergreen et al. model
[2] adequately fitted 35 of these data sets, while the Brain and
Cousens model [9] did not reveal significant hormesis at all. In this
study, the Brain and Cousens model [9] detected significant
hormesis in 22 out of 23 hormetic data sets while the Cedergreen
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33432Figure 4. Both logistic hormetic models equally suitable. Dose-response relationships for effects of different phytotoxins on root growth of
Amaranthus hybridus (A), Lactuca sativa (B–F), or Medicago sativa (G) and for effects of root exudates of Triticum aestivum on root growth of Sinapis
alba (H) and their description by the hormetic dose-response models after Brain and Cousens [9] (grey curve) or Cedergreen et al. [2] (black curve).
Both models provided an adequate, marginally varying fit. Error bars represent standard deviation.
doi:10.1371/journal.pone.0033432.g004
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where only the Brain and Cousens model [9] was able to capture
the apparent significance of hormesis. These five cases were all
characterized by a more or less pronounced drop of the
Cedergreen et al. curve [2] before the initiation of the hormetic
effect. According to Cedergreen et al. [2] the drop results if the
value of a is preset too high. However, the a values of the five
curves ranged between 0.45 and 0.62 and were, thus, considerably
lower as the a values of four other Cedergreen et al. curves [2],
showing a negligible drop (Figures 3G, 3H, 4B, and 4H; a=0.81–
2.50). Thus, the value of a may not be decisive for initiating a
pronounced drop. Anyhow, results indicate that a pronounced
drop of the Cedergreen et al. curve [2] at low doses makes it more
difficult to obtain a significant f value. On the other hand, this
shape of the curve visually better described this pre-hormetic
toxicity pattern than the steadily increasing Brain and Cousens
model [9] which was unable to capture this phenomenon. The
question is, however, if capturing this phenomenon is imperative,
i.e., if it is actually biologically relevant and if ignoring it by
applying the Brain and Cousens model [9] makes a difference.
Evaluating the biological significance of pre-hormetic toxicity is
intricate as little information exists on this topic in plant biology
and often just one dose below the control value suggests its
existence. However, current results confirm that the phenomenon
is regularly observed for parthenin, a hormetin showing hormesis
as a result of overcompensation of initial inhibitory responses
[13,14]. Furthermore, Sinkkonen et al. [27] observed low doses of
toxicants to inhibit the most vigorous individuals within a plant
population and claimed that low-dose stimulatory effects are not
the only biological phenomenon occurring in the low dose range.
As demonstrated, the Cedergreen et al. model [2] may offer a
means to quantify this phenomenon. Comparing the CI95 for the
estimate of d with that of ymin may allow concluding on its
significance following the procedure for the significance test for the
f estimate. Schabenberger et al. [10] pointed out that if parameters
are expressed relative to a baseline treatment, a direct estimate of a
treatment difference is obtained. According to this, significance of
the observed low-dose toxicity would be given in the present study
at the 0.05 probability level for two parthenin curves (Figure 2A–
B) as here the CI95 for the relative estimates of ymin did not cover
the value 100. Nevertheless, much more research effort will be
needed to unravel this low-dose toxicity pattern.
Regarding the relative bias incurred by ignoring this low dose
toxicity, current results suggest that primarily hormetic quantities
may be at risk. However, the magnitude of observed differences
between M, LDS, and ymax estimates of both models was with 4–
25% as distinct as the variations observed in cases where both
models provided a similar fit (0–26%). Thus, ignoring this low dose
phenomenon did not exceed the magnitude of observed inherent
variation between both models. This speaks in favor of a
statistically sound Brain and Cousens modeling [9] of hormesis
in such cases and reveals the convenience of this model.
Additionally, the one data set where the Brain and Cousens
model [9] proved superior and the eight data sets where both
models proved equally suitable further demonstrates the compet-
itiveness of the model.
Foreightdatasetsthe Cedergreenetal.model[2]was statistically
and graphically clearly inferior modeling the hormetic effects.
Although in each of these cases the use of the Brain and Cousens
model [9] was statistically legitimate in terms of lack-of-fit and
Pseudo-R
2, the graphical agreement with the observed data was so
poor that substantial deviationsfrom thebetterfitting Cedergreen et
al. curves [2] appeared. As a result, the magnitude of deviations
between estimated effective doses was severe and ranged between
3–1768%. Deviations were most pronounced for the three flattish
glyphosate curves (139–1758%) confirming the statement of
Cedergreen et al. [2] that the Brain and Cousens model [9] can
especially cause problems with data describing inherently low
slopes. Based on this it is to assume that conclusions drawn from
these deviant estimates may considerably diverge at all response
levels depending on the model used. This confirms the statement of
Schabenberger et al. [10] that assessments of treatment effects are
conditional on the correctness of the selected model. Therefore, a
sole reliance on statistical measures of lack-of-fit for judging the
aptness of a hormetic model can be fatal. Especially the Pseudo-R
2
measure proved inapt in this regard by pretending a satisfactory fit
withvaluesbetween 0.874 and 0.967 forthepoorlyfittingBrain and
Cousenscurves[9].Thisstatisticalmeasureshouldthereforeonlybe
used as a supplemental criterion. Furthermore, a graphical
assessment of the conformity of observed and fitted values is an
essential requirement for hormetic model selection.
In cases where both models were statistically and graphically
equally suitable to describe the hormetic response, there was still
some variation between estimated dosages albeit unlikely signif-
icant. If the observed magnitudes of relative bias (0–26%) may
influence the assessment of treatment effects may depend on the
application and set of empirical data. However, hormetic
quantities and especially M estimates clearly pose a higher risk
in this regard due to the observed higher variability between
model predictions as compared to ED50 dosages. Therefore, in
cases where both models offer a suitable fit, a critical question can
be how one should objectively decide which model to use.
Limitations
This study as well as others indicated that the Brain and Cousens
model [9] can cause problems when fitting data displaying an early
increase in responses at low doses, a broad hormetic dose range,
and/or gently sloping curves, while the Cedergreen et al. model [2]
only seems to cause problems in case of pre-hormetic toxicity.
Furthermore, both models may potentially be limited in case of
extremely steep sloping data sets. Cedergreen et al. [2] claimed the
necessityto constrainfand bestimatesasa furtherseriousdrawback
of the Brain and Cousens model [9]. However, in the present study,
as in previous applications, f and b could be easily estimatedwithout
restrictions (e.g., [11,13]). In contrast, there were only six curves in
the present study out of the 17 proving significant hormesis with the
Cedergreen et al. model [2] were the value of a could be estimated
without restriction (Tables S2, S4, and S6). Hence, 11 curves
required to fix a in order to achieve significant f estimates. Among
these curveswere for exampleallthree glyphosatedata setsshowing
4–6 hormetic doses and, thus, most likely enough data to
adequately estimate the size of a. Thus, the drawback of restricted
parameter estimation seems to apply as well for the Cedergreen
et al. model [2]. Hence, both models have real and potential
shortcomings raising the question of how competitive they are
capturing the diversity of hormesis compared to alternative
hormetic models such as the switching functions proposed by
Schabenberger and Birch [3] or by Dette et al. [26]. These
functions have been rarely addressed for plant hormesis.
Both models now allow the estimation of effective hormetic
dosages by properly reparameterized functions. One drawback
that seems to remain with this approach is the fact that for each
reparameterization, the ensuing model needs to be fitted based on
suitable starting values of parameters to ensure convergence of the
estimation algorithm [2]. This requires some skill and can be
laborious. A further pending question is the competitiveness of
reparameterization regarding the ease of model fitting and
statistical inference of effective dosages compared to other
Modelling Hormesis Quantities
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worth exploring.
Clearly both models and the approach of reparameterization
have shortcomings with regard to modeling, however, together
they provide a powerful means to model, prove and quantify a
wide range of hormetic responses. Despite this, the current
approach should not be adopted as a law-of-nature as in some
cases other nonlinear models may provide a better fit to the data
[3,10]. Which model best fits observed responses must be
statistically and graphically reassessed for every set of empirical
data. An uncritical application of a particular model can cause
serious misinterpretation especially regarding effective doses
quantifying hormesis.
Supporting Information
Table S1 Syntax for parameterizations of the Brain and
Cousens model [9] after Schabenberger et al. [10].
(PDF)
Table S2 Syntax for parameterizations of the Ceder-
green et al. model [2].
(PDF)
Table S3 Regression Parameters for curves displayed
in Figure 1.
(PDF)
Table S4 Regression Parameters for curves displayed
in Figure 2.
(PDF)
Table S5 Relative bias (%) between effective dosages
estimations from curves displayed in Figures 2, 3, and 4.
(PDF)
Table S6 Regression Parameters for curves displayed
in Figure 3.
(PDF)
Table S7 Regression Parameters for curves displayed
in Figure 4.
(PDF)
Acknowledgments
The technical assistance of Despina Savvidou and Elisabeth Zimmermann
is greatly acknowledged.
Author Contributions
Conceived and designed the experiments: RGB. Performed the experi-
ments: RGB. Analyzed the data: RGB. Contributed reagents/materials/
analysis tools: HPP. Wrote the paper: RGB. Revised the manuscript: RGB
HPP.
References
1. Calabrese EJ, Blain RB (2011) The hormesis database: the occurrence of
hormetic dose responses in the toxicological literature. Regul Toxicol Pharm 61:
73–81.
2. Cedergreen N, Ritz C, Streibig JC (2005) Improved empirical models describing
hormesis. Environ Toxicol Chem 24: 3166–3172.
3. Schabenberger O, Birch JB (2001) Statistical dose-response models with
hormetic effects. Hum Ecol Risk Assess 7: 891–908.
4. Calabrese EJ (2005) Paradigm lost, paradigm found: the re-emergence of
hormesis as a fundamental dose response model in the toxicological sciences.
Environ Pollut 138: 379–412.
5. Duke S, Cedergreen N, Belz R, Velini E (2006) Hormesis: is it an important
factor in herbicide use and allelopathy? Outlooks Pest Manag 17: 29–33.
6. Cedergreen N (2008) Herbicides can stimulate plant growth. Weed Res 48:
429–438.
7. Finney DJ (1976) Radioligand assay. Biometrics 32: 721–740.
8. Streibig JC (1980) Models for curve-fitting herbicide dose-response data. Acta
Agric Scand 30: 59–63.
9. Brain P, Cousens R (1989) An equation to describe dose responses where there is
stimulation of growth at low doses. Weed Res 29: 93–96.
10. Schabenberger O, Tharp BE, Kells JJ, Penner D (1999) Statistical tests for
hormesis and effective dosages in herbicide dose response. Agron J 91: 713–721.
11. Belz RG, Cedergreen N, Sørensen H (2008) Hormesis in mixtures – can it be
predicted? Sci Total Environ 404: 77–87.
12. Andresen M, Cedergreen N (2010) Plant growth is stimulated by tea-seed
extract: a new natural growth regulator? HortScience 45: 1848–1853.
13. Belz RG, Cedergreen N (2010) Parthenin hormesis in plants depends on growth
conditions. Environ Exp Bot 69: 293–301.
14. Belz RG (2008) Stimulation versus inhibition – bioactivity of parthenin, a
phytochemical from Parthenium hysterophorus L. Dose-Response 6: 80–96.
15. Cedergreen N (2007) The occurence of hormesis in plants and algae. Dose-
Response 5: 150–162.
16. Cedergreen N, Felby C, Porter JR, Streibig JC (2009) Chemical stress can
increase crop yield. Field Crops Res 114: 54–57.
17. Cedergreen N, Olesen CF (2010) Can glyphosate stimulate photosynthesis?
Pestic Biochem Phys 96: 140–148.
18. Calabrese EJ (2008) Hormesis and medicine. Brit J Clin Pharmaco 66: 594–617.
19. Petersen J, Belz R, Walker F, Hurle K (2001) Weed suppression by release of
isothiocyanates from turnip-rape mulch. Agron J 93: 37–43.
20. Belz RG, Reinhardt CF, Foxcroft LC, Hurle K (2007) Residue allelopathy in
Parthenium hysterophorus L. – does parthenin play a leading role? Crop Prot 26:
237–245.
21. Gagliardo RW, Chilton WS (1992) Soil transformation of 2(3H)-benzoxazolone
of rye into phytotoxic 2-amino-3H-phenoxazin-3-one. J Chem Ecol 18:
1683–1691.
22. Belz RG, Hurle K, Duke SO (2005) Dose-response – a challenge for allelopathy?
Nonlinearity Biol Toxicol Med 3: 173–211.
23. Belz RG, Hurle K (2004) A novel laboratory screening bioassay for crop seedling
allelopathy. J Chem Ecol 30: 175–198.
24. Liu Y, Chen X, Duan S, Feng Y, An M (2011) Mathematical modeling of plant
allelopathic hormesis based on ecological-limiting-factor models. Dose-Response
9: 117–129.
25. An M, Johnson IR, Lovett JV (1993) Mathematical modeling of allelopathy:
biological response to allelochemicals and its interpretation. J Chem Ecol 19:
2379–2388.
26. Dette H, Pepelyshev A, Wong WK (2011) Optimal experimental design
strategies for detecting hormesis. Risk Anal 31: 1949–1960.
27. Sinkkonen A, Myyra ¨ M, Penttinen OP, Rantalainen AL (2011) Selective toxicity
at low doses: experiments with three plant species and toxicants. Dose-Response
9: 130–143.
Modelling Hormesis Quantities
PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e33432